Evidence map›Paper›PMID 34099848›Full record

ArticleCommunications biology2021

Functional in vivo characterization of sox10 enhancers in neural crest and melanoma development.

Rebecca L Cunningham, Eva T Kramer, Sophia K DeGeorgia, Paula M Godoy, Anna P Zarov, Shayana Seneviratne, Vadim Grigura, Charles K Kaufman

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Reactivation of an embryonic cardiac neural crest transcriptional profile during zebrafish heart regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. SpecificbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. METTL3-dependent mCell death & disease · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rebecca L CunninghamDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-8219-3480
Eva T KramerDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-1363-3125
Sophia K DeGeorgiaDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-0539-0039
Paula M GodoyDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.
Anna P ZarovDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-4965-9167
Shayana SeneviratneSchool of Arts and Sciences, Washington University in Saint Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-8744-4437
Vadim GriguraDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA.
Charles K KaufmanDivision of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO, USA. ckkaufman@wustl.edu.ORCID http://orcid.org/0000-0003-3122-1677
Washington University in St. Louis · US

Funding

TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Defining Transcriptional Regulators of Melanoma Initiation using ZebrafishR01CA240633 · NCI · WASHINGTON UNIVERSITY · PI KAUFMAN, CHARLES KORE · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA240633NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

The role of a neural crest developmental transcriptional program, which critically involves Sox10 upregulation, is a key conserved aspect of melanoma initiation in both humans and zebrafish, yet transcriptional regulation of sox10 expression is incompletely understood. Here we used ATAC-Seq analysis of multiple zebrafish melanoma tumors to identify recurrently open chromatin domains as putative melanoma-specific sox10 enhancers. Screening in vivo with EGFP reporter constructs revealed 9 of 11 putative sox10 enhancers with embryonic activity in zebrafish. Focusing on the most active enhancer region in melanoma, we identified a region 23 kilobases upstream of sox10, termed peak5, that drives EGFP reporter expression in a subset of neural crest cells, Kolmer-Agduhr neurons, and early melanoma patches and tumors with high specificity. A ~200 base pair region, conserved in Cyprinidae, within peak5 is required for transgenic reporter activity in neural crest and melanoma. This region contains dimeric SoxE/Sox10 dimeric binding sites essential for peak5 neural crest and melanoma activity. We show that deletion of the endogenous peak5 conserved genomic locus decreases embryonic sox10 expression and disrupts adult stripe patterning in our melanoma model background. Our work demonstrates the power of linking developmental and cancer models to better understand neural crest identity in melanoma.

Indexed as

AnimalsDisease Models, AnimalEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticMelanomaNeural CrestSOXE Transcription FactorsZebrafishZebrafish Proteinssox10 protein, zebrafishSOXE Transcription FactorsZebrafish Proteins

Identifiers

PMID34099848
PMCPMC8184803
OpenAlexW3168779990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.